Series C - NeoChord
Investment Firm
Overview
NeoChord is a medical device company that develops devices that allow mitral valve repair to be performed on a beating heart.
Announced Date
Jun 09, 2015
Funding Type
Series C
Highlights
Location
United States, North America
Social
Participant Investors
6
Round Details and Background
NeoChord raised $20000000 on 2015-06-09 in Series C
NeoChord is a medical device company that develops devices that allow mitral valve repair to be performed on a beating heart.
Company Funding History
13
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jun 09, 2015 |  Series C - NeoChord | 6 | - | 20.0M |
| Jun 16, 2009 | Series A - NeoChord | - | 3.4M | |
| Oct 25, 2013 | Debt Financing - NeoChord | 1 | - | 3.0M |
| Jul 29, 2011 | Series B - NeoChord | 1 | - | 5.1M |
Recent Activity
There is no recent news or activity for this profile.